Problems in treating pancreatitis with enzyme inhibitors.
D000681:Amylases / Q000097:blood; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D002115:Calciphylaxis / Q000188:drug therapy; D004285:Dogs; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008049:Lipase / Q000097:blood; D008962:Models, Theoretical; D009929:Organ Size; D010179:Pancreas / Q000473:pathology*; D010195:Pancreatitis / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology / Q000401:mortality; D010447:Peptide Hydrolases / Q000097:blood; D011183:Postoperative Complications / Q000453:epidemiology; D051381:Rats; D014357:Trypsin
D007611:Aprotinin; D008049:Lipase; D000681:Amylases; D010447:Peptide Hydrolases; D014357:Trypsin